Market Overview
The global sperm count test market encompasses laboratory-based semen analysis, at-home diagnostic kits, and connected point-of-care devices used to assess male fertility. Valued at roughly $1.73 billion in 2025, the market is expanding as male reproductive health garners greater clinical and consumer attention. Adjacent segments, such as sperm banking and storage, are projected to reach approximately $8 billion by 2030, reflecting the broader ecosystem of services tied to sperm diagnostics and preservation.
- •Market valued at approximately $1.73 billion in 2025
- •Annual growth rate of roughly 8.04%
- •Closely related sperm banking market projected near $8 billion by 2030
Growth Drivers
A primary growth catalyst is the documented global decline in sperm concentrations and testosterone levels reported in medical literature, which has increased clinical demand for diagnostic testing. Greater access to affordable testing options, including home-use kits, is lowering barriers for men who previously faced limited screening opportunities. Within healthcare systems, sperm function testing is being evaluated for cost-benefit potential, with analyses suggesting it could deliver cost-neutral or savings-oriented outcomes in treatment pathways for unexplained infertility.
- •Accelerating global decline in sperm concentrations driving diagnostic demand
- •Transition toward cost-effective home diagnostic devices improving accessibility
- •Economic analyses of sperm function testing showing potential healthcare savings
Segmentation and Regional Analysis
The market spans traditional laboratory-based semen analysis, smartphone-connected point-of-care systems, and consumer-grade at-home devices, each serving distinct user bases from clinics to individuals. Latin America and Brazil represent a growing regional market, where narrative reviews highlight expanding fertility services and increasing demand for associated diagnostic tools. Products such as YO, SEEM, and ExSeed exemplify the shift toward simplified, accessible testing devices designed to overcome barriers of cost, geography, and clinical access.
- •Market segmented across laboratory analysis, point-of-care, and home diagnostic devices
- •Latin America and Brazil showing expanding fertility and diagnostic market growth
- •Home-use devices like YO, SEEM, and ExSeed broadening market reach
Trends and Outlook
What are the recent trends and outlook?
Smartphone-connected point-of-care systems represent a significant trend, enabling users to perform and analyze semen samples outside conventional laboratory settings. Continued innovation in male contraception and reproductive technology is expected to broaden the ecosystem around sperm diagnostics, with related biotechnology segments drawing increased investment. Regional markets such as Latin America are anticipated to contribute meaningfully to future growth as fertility services expand and healthcare infrastructure for male reproductive diagnostics improves.
- •Smartphone-based at-home semen analysis systems gaining clinical validation
- •Expanding male reproductive health and contraceptive technology sectors
- •Latin American fertility markets identified as a key growth area
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.